Working...
ClinicalTrials.gov
ClinicalTrials.gov Menu

Continuous Glucose Monitoring During Intecorse in Young Adults With Type 1 Diabetes

The safety and scientific validity of this study is the responsibility of the study sponsor and investigators. Listing a study does not mean it has been evaluated by the U.S. Federal Government. Know the risks and potential benefits of clinical studies and talk to your health care provider before participating. Read our disclaimer for details.
ClinicalTrials.gov Identifier: NCT02750111
Recruitment Status : Recruiting
First Posted : April 25, 2016
Last Update Posted : October 19, 2017
Sponsor:
Collaborator:
Sheba Medical Center
Information provided by (Responsible Party):
Dr. Orit Hamiel, Sheba Medical Center

Brief Summary:
Determine the incidence of hypoglycemia during / after sexual intercourse among young adults with type 1 diabetes using continuous -type sugar meter IPRO for a week.

Condition or disease
Diabetes Mellitus Type 1

Detailed Description:
Determine the incidence of hypoglycemia during / after sexual intercourse among young adults with type 1 diabetes using continuous -type sugar meter IPRO for a week.

Layout table for study information
Study Type : Observational
Estimated Enrollment : 50 participants
Observational Model: Cohort
Time Perspective: Prospective
Official Title: Continuous Glucose Monitoring During Intecorse in Young Adults With Type 1 Diabetes
Study Start Date : May 2016
Estimated Primary Completion Date : May 8, 2018
Estimated Study Completion Date : May 8, 2018

Resource links provided by the National Library of Medicine

MedlinePlus related topics: Diabetes Type 1




Primary Outcome Measures :
  1. Blood Glucose [ Time Frame: week ]
    Continuous glucose monitor for a week



Information from the National Library of Medicine

Choosing to participate in a study is an important personal decision. Talk with your doctor and family members or friends about deciding to join a study. To learn more about this study, you or your doctor may contact the study research staff using the contacts provided below. For general information, Learn About Clinical Studies.


Layout table for eligibility information
Ages Eligible for Study:   18 Years to 50 Years   (Adult)
Sexes Eligible for Study:   All
Accepts Healthy Volunteers:   No
Sampling Method:   Probability Sample
Study Population
Type 1 diabetes
Criteria

Inclusion Criteria:

type 1 diabetes

Exclusion Criteria:

type 2 diabetes other concomitant disease


Information from the National Library of Medicine

To learn more about this study, you or your doctor may contact the study research staff using the contact information provided by the sponsor.

Please refer to this study by its ClinicalTrials.gov identifier (NCT number): NCT02750111


Contacts
Layout table for location contacts
Contact: Orit Hamiel, Prof. +97235305015 orit.hamiel@sheba.health.gov.il

Locations
Layout table for location information
Israel
Sheba_Medical_Center Recruiting
Ramat Gan, Israel, 52621
Contact: Orit Hamiel, prof    +97235305015    orit.hamiel@sheba.health.gov.il   
Sponsors and Collaborators
Dr. Orit Hamiel
Sheba Medical Center
Investigators
Layout table for investigator information
Principal Investigator: Orit Hamiel, Prof. Sheba Medical Center

Layout table for additonal information
Responsible Party: Dr. Orit Hamiel, Head department of Pediatric Endocrinology, Sheba Medical Center
ClinicalTrials.gov Identifier: NCT02750111     History of Changes
Other Study ID Numbers: 2942.1
First Posted: April 25, 2016    Key Record Dates
Last Update Posted: October 19, 2017
Last Verified: October 2017
Individual Participant Data (IPD) Sharing Statement:
Plan to Share IPD: Yes

Additional relevant MeSH terms:
Layout table for MeSH terms
Diabetes Mellitus
Diabetes Mellitus, Type 1
Glucose Metabolism Disorders
Metabolic Diseases
Endocrine System Diseases
Autoimmune Diseases
Immune System Diseases